The importance of drug-drug interactions in the DAA era.
about
Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive MedicationsMedication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.How to optimize current therapy of HCV genotype 1 infection with boceprevir.Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.The current state and future prospects of chronic hepatitis C virus infection treatment.Common GI Drug Interactions in the Elderly.Antiviral drug discovery: broad-spectrum drugs from nature.Drug interactions with new hepatitis C oral drugs.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.Drug interactions in HIV-infected patients treated for hepatitis C.Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications.
P2860
Q28069639-A3B1C2FB-1F17-4363-B0AA-78D2BF4A7EC6Q34143327-867B8F51-A61D-4565-94FD-B48D758586BDQ38174241-782AFB26-57DC-4CEB-94F6-D06AA987F7D8Q38192047-DCE7B6D4-B66B-42F2-89EC-D4AA36C0F024Q38203823-7730C043-377E-4D57-AF9E-40493657968DQ38217350-592761CE-D1BF-41CB-8211-A3BBE161937FQ38230328-32F17503-8ACF-4E3B-B412-B9F96FA6FDBCQ38260235-095C58BF-AA6A-4B03-85A2-D4A75AD317DBQ38305640-479CCD3C-85FC-47A4-9645-8A15F0FBA148Q38554604-EF273E17-A556-40E5-BE3C-20B2BA80E04EQ38703524-7505D553-197C-410B-9C39-43C06A7F6F29Q40143109-778272CC-EBC9-405D-9036-2184414FF589Q40697687-60856489-04D5-45C1-BF5A-1FD0CC55D4E3Q40784890-D1C0C48E-F327-4513-A302-1E2A5F24DE1EQ47551957-1CE1C96E-EA81-4660-A90C-1A7838C41089
P2860
The importance of drug-drug interactions in the DAA era.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The importance of drug-drug interactions in the DAA era.
@en
type
label
The importance of drug-drug interactions in the DAA era.
@en
prefLabel
The importance of drug-drug interactions in the DAA era.
@en
P1476
The importance of drug-drug interactions in the DAA era.
@en
P2093
David Back
Laura Else
P304
P356
10.1016/J.DLD.2013.07.008
P478
45 Suppl 5
P577
2013-09-01T00:00:00Z